Key Market Indicator:
F&G: 63
25.251,30 NASDAQ · 49.031,00 DOW · 6.888,45 S&P · 4.662,97 Gold · 63,09 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
08.08.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST
Article
News Preview
Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be...
Themefolio
Profiler
Peergroup
© Newsfile
08.08.2025
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis
Article
News Preview
Dublin, Ireland--(Newsfile Corp. - August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply agreement with Takeda (TSE: 4502) (NYSE: TAK), to produce Mesalazine MMX 1200 mg (marketed as Liald...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.08.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
Article
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 8 AUGUST 2025 at 9.30 EEST        ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van UBS Group AG
Article
News Preview
Leuven, BELGIË – 7 augustus 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transpa...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from UBS Group AG
Article
News Preview
Leuven, BELGIUM – August 7, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on August 1, 2025, from UBS G...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion beëindigt RD-programma voor geografische maculaire degeneratie en focust op nieuwe CRO-activiteiten
Article
News Preview
Leuven, België, 7 augustus 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutische vennootschap gevestigd in Leuven, kondigt vandaag de definitieve stopzetting aan van zijn preklinisch onderzoeksprogramma gericht op de ontwikkeling van nieuwe therapeutische doelwitten voor geografische maculaire degeneratie (GA). Dit pro...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Ends RD Program in Geographic Atrophy and Refocuses on New CRO Activities
Article
News Preview
Leuven, BELGIUM – August 7, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced the definitive termination of its preclinical research program aimed at developing new therapeutic targets for geographic atrophy (GA). This program relied on a high-throughput gene...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion met fin à son programme de RD sur la dégénérescence maculaire géographique et se recentre sur ses nouvelles activités de CRO
Article
News Preview
Louvain, Belgique, 7 août 2025, 18h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce aujourd'hui la cessation définitive de son programme de recherche préclinique dédié au développement de nouvelles cibles thérapeutiques pour la d&eacut...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
Article
News Preview
Press Release – No. 11 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Financial Results for the First Half of 2025
Article
News Preview
August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call
Article
News Preview
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the second quarter 2025 after the market closes on Thursday, August 14, 2025. Management will host a webcast/tel...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
07.08.2025
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore reports second quarter financial results and provides a business update
Article
News Preview
KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.08.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
Article
News Preview
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25  Significant recovery and further expansion of order entry compared to prior year   JENA, 7 August 2025 Carl Zeiss Meditec generated revenue of €1,600.1m in the first nine months of fiscal year 2024/25 (prior year: €1,486.5m), including the DORC consolidation, c......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.08.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt Umsatz- und Ergebniswachstum nach neun Monaten 2024/25
Article
News Preview
Carl Zeiss Meditec erzielt Umsatz- und Ergebniswachstum nach neun Monaten 2024/25  Auftragseingang gegenüber Vorjahr weiter deutlich erholt und ausgebaut   JENA, 7. August 2025 Carl Zeiss Meditec erzielte in den ersten neun Monaten des Geschäftsjahres 2024/25 inklusive der DORC-Konsolidierung einen Umsatz von rund 1.600,1 Millionen Euro (Vj. ......
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA Notice of Half Year 2025 Results and Conference Call
Article
News Preview
HY25 results webcast to take place on Thursday, 28 August 2025 at 3pm CEST...
Themefolio
Profiler
Peergroup
© ActuNews
06.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – August 6, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on August 6, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
06.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 6 augustus 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transpa...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.08.2025
ISIN: NL0000009538
Koninklijke Philips NV
PHIA
LISTED
EURONEXT
Doctor-patient trust is key to unlocking AI's potential to improve healthcare in Australia, finds Philips' Future Health Index Report
Article
News Preview
EQS Newswire / 06/08/2025 / 10:00 CET/CEST Two-thirds (66%) of Australians welcome technology for improved care, but more than half (53%) are concerned it will mean less face time with their doctor. Three in four (74%) Australian healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.08.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce first half-year results 2025 on 13 August 2025
Article
News Preview
Hamburg, Germany, 06 August 2025: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) will announce its half-year interim report for the first six months of 2025 on Wednesday, 13 August 2025. The Company is going to hold a conference call to discuss the results as well as provide an u......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.08.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Halbjahr 2025 am 13. August 2025
Article
News Preview
Hamburg, 06. August 2025: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) veröffentlicht am Mittwoch, 13. August 2025, ihren Halbjahresbericht für die ersten sechs Monate 2025. In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem B......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.08.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce first half-year results 2025 on 13 August 2025
Article
News Preview
HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its half-year interim report for the first six months of 2025 on Wednesday, 13 August 2025.The Company is going to hold a conference call to discuss the results as well as p...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Umsetzung des Aktiensplits durch Ausgabe von Gratisaktien erfolgt am 15. August 2025
Article
News Preview
Berlin, 5. August 2025. Nachdem alle formellen Voraussetzungen des am 18. Juni 2025 von der Hauptversammlung beschlossenen Aktiensplits erfüllt sind, erfolgt nun die bankenseitige Umsetzung dieser Kapitalmaßnahme der Eckert & Ziegler SE (ISIN DE0005659700). Danach stehen den Aktionären der Gesellschaft aufgrund ihres bisherigen Aktienbesitzes i......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
Article
News Preview
Berlin, 5 August 2025. All formal requirements of the stock split resolved by the Annual General Meeting on 18 June 2025 have now been met and the timeline for implementation of this capital measure of Eckert & Ziegler SE (ISIN DE0005659700) on the bank side is set. Accordingly, the company's shareholders will be entitled to new shares in the r......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance
Article
News Preview
SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance Q3 2025 revenues up 3% yoy at constant currencies to EUR 256m Q3 2025 EBITDA up 11% yoy to EUR 83m, with a quarterly margin of 32.4% (31.7% at constant currencies) Organic revenue growth for FY 2025 is expected to be around 6.0%, at the lower end of management e......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma veröffentlicht vorläufiges Ergebnis für das dritte Quartal 2025 und präzisiert Prognose für das Geschäftsjahr 2025
Article
News Preview
SCHOTT Pharma veröffentlicht vorläufiges Ergebnis für das dritte Quartal 2025 und präzisiert Prognose für das Geschäftsjahr 2025 Umsatz in Q3 2025 steigt währungsbereinigt um 3 % auf 256 Mio. Euro EBITDA wächst in Q3 2025 um 11 % auf 83 Mio. Euro, die EBITDA Marge beträgt 32,4 % (31,7 % währungsbereinigt) Das organische Wachstum für das Geschäft......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin
Article
News Preview
SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma specifies FY 2025 guidance: Organic revenue growth for FY 2025 is expected to be around 6.0%, at the lower end of management expectations between 6.0% and 9.0% (“high-single digit”). The EBITDA margin for FY 2025 is expected to be around 28.0%, above the p......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.08.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma präzisiert die Prognose für Umsatzwachstum und EBITDA-Marge für das Geschäftsjahr 2025
Article
News Preview
SCHOTT Pharma präzisiert die Prognose für Umsatzwachstum und EBITDA-Marge für das Geschäftsjahr 2025 SCHOTT Pharma präzisiert die Prognose für das Geschäftsjahr 2025: Das organische Wachstum für das Geschäftsjahr 2025 wird ungefähr 6,0 % betragen, was am unteren Ende der Management-Erwartung von 6,0 % bis 9,0 % liegt („im hohen einstelligen Bereic......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozess zu initiieren
Article
News Preview
Gerresheimer separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozess zu initiieren Beste Wachstumschancen für Moulded Glass als starke, unabhängige Einheit mit acht Werken in Europa, Amerika und Asien Weiterer Schritt in der Transformation der Gerresheimer zu einem reinen System- und Lösungsanbieter für die Pharma- und Biotech......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
Article
News Preview
Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process  Best growth opportunities for Moulded Glass as a strong, independent unit with eight plants across Europe, the Americas and Asia Further step in Gerresheimer's strategic transformation into a system and solution provider purely for the pharma and biotech in......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
Article
News Preview
Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process Duesseldorf, August 04, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") has completed the strategic review of its moulded glass business and decided to separate the business and intends to subsequently initiate a sales process for the business u......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer AG separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozess zu initiieren
Article
News Preview
Gerresheimer AG separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozesses zu initiieren Düsseldorf, 04. August 2025. Die Gerresheimer AG (ISIN: DE000A0LD6E6, „Gerresheimer“) hat die strategische Überprüfung ihres Moulded-Glass-Geschäfts abgeschlossen und entschieden, das Geschäft zu separieren und beabsichtigt anschließend, ei......
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion obtient une offre de financement revue à la hausse à 30 M EUR pour lancer la diversification de sa trésorerie en actifs numériques
Article
News Preview
Louvain, Belgique, 4 août 2025, 18h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce avoir reçu une offre indicative de financement renforcée de la part d'Atlas Special Opportunities, portant sur un montant total de 30 millions d'euros. Cette proposition pr&ea...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion kondigt aan dat het een verbeterd indicatief financieringsaanbod van EUR 30 miljoen heeft gekregen om de diversificatie van een deel van zijn kasmiddelen naar digitale activa te starten
Article
News Preview
Leuven, BELGIË, 4 augustus 2025 – 18u00 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, kondigt aan dat het een verbeterd indicatief financieringsaanbod heeft ontvangen van Atlas Special Opportunities, voor een totaalbedrag van €30 miljoen. De voorgestelde f...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Article
News Preview
Leuven, Belgium, August 4, 2025 – 06:00 PM CEST – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces that it has received an improved indicative financing offer from Atlas Special Opportunities for a total amount of €30 million. The proposed financing would be structured in 10 successi...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.08.2025
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
Article
News Preview
Mural continues to explore strategic alternatives...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.08.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
First Berlin Equity Research GmbH: Formycon AG | Rating: Buy
Article
News Preview
Original-Research: Formycon AG - from First Berlin Equity Research GmbH 04.08.2025 / 11:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certai......
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion finalise l'acquisition d'Axiodis CRO et accélère la structuration de son pôle européen dédié à la donnée clinique
Article
News Preview
Oxurion annonce la réalisation complète de l'acquisition de 72?% du capital d'Axiodis CRO Cette opération marque la première étape dans la constitution d'un pôle intégré centré sur la donnée clinique Le Groupe intensifie les discussions avec d'autres cibles s...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Article
News Preview
Oxurion announces the full completion of the acquisition of a 72% equity stake in Axiodis CRO This transaction marks the first step in building an integrated platform focused on clinical data The Group is intensifying discussions with additional strategic targets in France and across Europe Leuven, Belgium, August 4, 2025 – 08:30 CEST &nd...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Article
News Preview
Oxurion kondigt de volledige afronding aan van de overname van 72% van het aandelenkapitaal van Axiodis CRO. Deze overnamne vormt de eerste stap in de uitbouw van een geïntegreerd platform rond klinische data. De Groep versnelt de gesprekken met aanvullende strategische partners in Frankrijk en de rest Europa. Leuven, BELGIË, 4 augu...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.08.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Article
News Preview
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.08.2025
ISIN: FR0010386334
Clariane SE
CLARI
LISTED
EURONEXT
Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m
Article
News Preview
        ...
Themefolio
Profiler
Peergroup
© BusinessWire
01.08.2025
ISIN: CA68617J1003
Organigram Global Inc
OGI
LISTED
NASDAQ
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025
Article
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. The Company will host a conference call to discuss its results...
Themefolio
Profiler
Peergroup
© EQS Newswire
31.07.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer hebt währungsbereinigte Umsatz- und Ergebnisprognose für 2025 an und erhöht Rückstellungen für Rechtsstreitigkeiten in den USA
Article
News Preview
Leverkusen, 31. Juli 2025 – Vor der Bekanntgabe der Geschäftsentwicklung des zweiten Quartals 2025 am Mittwoch, 6. August, informiert die Bayer AG über wesentliche Finanzkennzahlen. Für das Gesamtjahr 2025 hebt Bayer die währungsbereinigte (wb.) Umsatz- und Ergebnisprognose an, da sich das Geschäft der Division Pharmaceuticals im ersten Halbjahr be......
Themefolio
Profiler
Peergroup
© EQS Newswire
31.07.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
Article
News Preview
Leverkusen, July 31, 2025 – Ahead of the publication of its business results for the second quarter of 2025 on Wednesday, August 6, Bayer AG is providing an update on key financial figures. Due to a better-than-expected business performance at Pharmaceuticals in the first half of the year, Bayer is raising its full-year guidance for currency-adjust......
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed Reports Q2 2025 Financial Results and Business Updates
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its second quarter 2025 financial results and provided an update on business highlights. “We continue making significant progress across al...
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or “the Company”) (NASDAQ: SLP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
Availability of 2025 Half-Year Financial Report
Article
News Preview
Paris – July 31, 2025 – EUROAPI posted today its 2025 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2025. This document is available for consultation and downloading on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
Article
News Preview
COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 million....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex Announces Quarterly Dividend
Article
News Preview
WAYNE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2025, to shareholders of record at the close of business on August 15, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: US45783C2008
Instil Bio Inc
TIL
LISTED
NASDAQ
ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China
Article
News Preview
Partial responses observed in 80% of squamous NSCLC front-line patients and in 46% of non-squamous NSCLC front-line patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
Article
News Preview
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases a...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025
Article
News Preview
 ...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 30 juli 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparanti...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – July 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on July 29, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 12 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 300.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1 die aan Oxurion zal toelaten om te focussen op het ontwikkelen van innovatieve geneesmiddelen om h...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 12 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential m...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.07.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025
Article
News Preview
MADRID and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the half-year ended June 30, 2025 and provided a corporate update on recent developments....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.07.2025
ISIN: US83086J2006
Skye Bioscience Inc
SKYE
LISTED
NASDAQ
Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025
Article
News Preview
SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, August 7, 2025 at 1:30 p.m. PT/4:30 p.m. ET to discuss its second quarter 2025 f...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.07.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
Article
News Preview
CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) (“CSPC”) for SYH2086, a preclinical oral small molecule glucagon-like peptide-1 (GLP-1) recept...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 19.01.2026, Calendar Week 04, 19th day of the year, 346 days remaining until EoY.